We are studying whether metformin can help extend pregnancy by at least 5 days in individuals with preterm preeclampsia. Additionally, we aim to see if it improves health outcomes for mothers and their babies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Pre-eclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, often the liver and kidneys. It typically occurs after the 20th week of pregnancy and can lead to serious complications if not managed properly.
HELLP syndrome is a severe form of pre-eclampsia that can occur during pregnancy, characterized by hemolysis, elevated liver enzymes, and low platelet count. It can lead to serious complications for both the mother and the baby if not treated promptly.
Hypertensive disorders of pregnancy encompass a range of conditions characterized by high blood pressure during pregnancy, including gestational hypertension and pre-eclampsia. These conditions can pose risks to both the mother and the fetus.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.